Shuichiro Yasuhara
Kanazawa University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shuichiro Yasuhara.
Clinical and Experimental Hypertension | 1985
Isamu Miyamori; Shuichiro Yasuhara; Masatoshi Ikeda; Hideo Koshida; Yoshiyu Takeda; Toshio Morise; Kunio Nagai; Seiya Okamoto; Ryoyu Takeda
Prostacyclin (PGI2) generation in the mesenteric arteries from dexamethasone acetate (DX) and deoxycorticosterone acetate (DOCA) treated rats was assessed by ex vivo perfusion method. PGI2 generation which was measured by 6-keto-PGF1 alpha output in the perfusate was significantly reduced in DX treated rats at prehypertensive stage both under the basal conditions and in response to angiotensin (ANG) II, whereas in DOCA group rats, vascular PGI2 production was not impaired. Plasma renin activity (PRA) was significantly suppressed in DOCA but normal in DX rats. These results suggest that the reduced PGI2 generation in the resistance arteries may contribute to the development of hypertension induced by DX.
Clinical and Experimental Hypertension | 1987
Isamu Miyamori; Shuichiro Yasuhara; Ryoyu Takeda
Long-term effects of angiotensin converting enzyme inhibitors on split renal function were studied using a noninvasive radioisotopic method in five patients with renovascular hypertension. In the stenotic side the glomerular filtration rate which acutely decreased following captopril, tended to return toward pretreatment levels on prolonged captopril administration (up to 2 years), while the value remained unchanged in the nonstenotic side of the kidney. Effective renal plasma flow increased in both sides. During long-term captopril treatment, there were no significant changes in serum creatinine, sodium, potassium, and blood pressure control was maintained at the same level in an acute period. These results suggest that the glomerular filtration in the stenotic kidney of renovascular hypertension, which was acutely reduced, will not further deteriorate, but will increase after prolonged captopril treatment.
Nihon Naibunpi Gakkai zasshi | 1984
Hideo Koshida; Isamu Miyamori; Kunio Nagai; Masatoshi Ikeda; Yoshiyu Takeda; Shuichiro Yasuhara; Toshio Morise; Hiroaki Takimoto; Senshu Hifumi; Ryoyu Takeda
Studies were done to determine the role of endogenous prostaglandins (PGs) for norepinephrine (NE) clearance in 10 male borderline hypertensives (BHT) (age: 20-28) and six age-matched male normotensives (NT). Two experimental protocols were followed in these subjects: 10 min orthostasis with blood sampling (protocol I), and 100 ng/kg/min of L-NE infusion for 60 min at supine position. Blood was collected from indwelling catheter at every min for 10 min after stopping the NE infusion (protocol II). Plasma NE was measured by THI method using HPLC. Disappearance curve of plasma NE was analyzed following the two compartment open model. The orthostasis and the steady state NE infusion were repeated after 150 mg/day of indomethacin (Ind) for three days. There were significant increases in plasma NE after orthostasis in both groups: from 180.8 +/- 28.0 pg/ml to 346.2 +/- 78.0 pg/ml (p less than 0.05) in NT and from 120.1 +/- 12.8 pg/ml to 289.6 +/- 20.3 pg/ml (p less than 0.001) in BHT, but there were no significant differences between the two groups. Ind pretreatment did not alter these responses. The calculated half-time of the first exponential phase (T 1/2) was 1.50 +/- 0.07 min in NT which decreased to 0.98 +/- 0.10 min (p less than 0.05) after Ind pretreatment. In BHT, T 1/2 was 1.03 +/- 0.08 min (p less than 0.01 vs NT), which was not significantly changed after Ind. These results may suggest that endogenous PGs have some role(s) in NT for NE clearance, probably exerting inhibitory action on neuronal uptake. In BHT, neuronal uptake of NE is increased, probably due to an adaptation mechanism to elevated blood pressure.
European Journal of Nuclear Medicine and Molecular Imaging | 1998
Junichi Taki; Shuichiro Yasuhara; Tsuyoshi Takamatsu; Kenichi Nakajima; Ryozo Tatami; Syozo Ishise; Matsunari I; Teruhiko Takayama; Norihisa Tonami
American Journal of Hypertension | 1988
Isamu Miyamori; Shuichiro Yasuhara; Takao Matsubara; Hideaki Takasaki; Ryoyu Takeda
Clinical Science | 1984
Isamu Miyamori; Toshio Morise; Masatoshi Ikeda; Hideo Koshida; Yoshiyu Takeda; Shuichiro Yasuhara; Hiroaki Takimoto; Ryoyu Takeda
Endocrinologia Japonica | 1987
Isamu Miyamori; Shuichiro Yasuhara; Takao Matsubara; Seiya Okamoto; Masatoshi Ikeda; Hideo Koshida; Toshio Morise; Yoshiyu Takeda; Ryoyu Takeda; P. Vecsei
Japanese Circulation Journal-english Edition | 1983
Isamu Miyamori; Shuichiro Yasuhara; Masatoshi Ikeda; Hideo Koshida; Yoshiyu Takeda; Toshio Morise; Hiroaki Takimoto; Ryoyu Takeda
Folia Endocrinologica Japonica | 1983
Isamu Miyamori; Yoshiyu Takeda; Masatoshi Ikeda; Hideo Koshida; Shuichiro Yasuhara; Toshio Morise; Hiroaki Takimoto; Ryoyu Takeda; Tomoyoshi Nishino
Japanese Circulation Journal-english Edition | 1997
Tsuyoshi Takamatsu; Shuichiro Yasuhara; Ryozo Tatami; Syozo Ishise; Susumu Miyabo